Early-Life Glucocorticoid Exposure: The Hypothalamic-Pituitary-Adrenal Axis, Placental Function, and Long-term Disease Risk
The DOI matches its Crossref record; 431 of the 440 references it cites were found in a registry or an index.
Abstract
An adverse early-life environment is associated with long-term disease consequences. Adversity early in life is hypothesized to elicit developmental adaptations that serve to improve fetal and postnatal survival and prepare the organism for a particular range of postnatal environments. These processes, although adaptive in their nature, may later prove to be maladaptive or disadvantageous if the prenatal and postnatal environments are widely discrepant. The exposure of the fetus to elevated levels of either endogenous or synthetic glucocorticoids is one model of early-life adversity that contributes substantially to the propensity of developing disease. Moreover, early-life glucocorticoid exposure has direct clinical relevance because synthetic glucocorticoids are routinely used in the management of women at risk of early preterm birth. In this regard, reports of adverse events in human newborns have raised concerns about the safety of glucocorticoid treatment; synthetic glucocorticoids have detrimental effects on fetal growth and development, childhood cognition, and long-term behavioral outcomes. Experimental evidence supports a link between prenatal exposure to synthetic glucocorticoids and alterations in fetal development and changes in placental function, and many of these alterations appear to be permanent. Because the placenta is the conduit between the maternal and fetal environments, it is likely that placental function plays a key role in mediating effects of fetal glucocorticoid exposure on hypothalamic-pituitary-adrenal axis development and long-term disease risk. Here we review recent insights into how the placenta responds to changes in the intrauterine glucocorticoid environment and discuss possible mechanisms by which the placenta mediates fetal hypothalamic-pituitary-adrenal development, metabolism, cardiovascular function, and reproduction.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Multiple doses of antenatal betamethasone can improve pulmonary outcome in preterm infants but are associated with decreased newborn weight, length, and head circumference (113-116).”
From Congenital Adrenal Hyperplasia Due to Steroid 21-Hydroxylase Deficiency: An Endocrine Society* Clinical Practice Guideline (2018) · cites this paper as [116]
Citations
Cites
2 retracted
Items 401–431 of 431
Crowther, C. A., Aghajafari, F., Askie, L. M., Asztalos, E. V., Brocklehurst, P., Bubner, T., Doyle, L. W., Dutta, S., Garite, T. J., Guinn, D. A., et al. (2012) · Systematic Reviews · doi:10.1186/2046-4053-1-12 · Cited by 21
Imperatore, A., Li, W., Petraglia, F., & Challis, J. R. G. (2009) · Reproductive Sciences · doi:10.1177/1933719109332830 · Cited by 20
Self-citationNykänen, P., Raivio, T., Heinonen, K., Jänne, O. A., & Voutilainen, R. (2007) · European Journal of Endocrinology · doi:10.1530/eje-06-0672 · Cited by 20
Schneider, U., Arnscheidt, C., Schwab, M. G., Haueisen, J., Seewald, H. J., & Schleußner, E. (2011) · Reproductive Sciences · doi:10.1177/1933719110381140 · Cited by 19
Shafrir, E., Barash, V., Zederman, R., Kissilevitz, R., & Diamant, Y. Z. (1994) · PubMed · Cited by 18
Drugs and the Placenta—A Workshop Report
Shiverick, K. T., Slikker, W., Rogerson, S. J., & Miller, R. K. (2003) · Placenta · doi:10.1053/plac.2002.0957 · Cited by 17
Dodic, M., Tersteeg, M., Jefferies, A. J., Wintour, E. M., & Moritz, K. M. (2003) · Journal of Endocrinology · doi:10.1677/joe.0.1790275 · Cited by 16
Aida, K., Wang, X. L., Wang, J., Li, C., McDonald, T. J., & Nathanielsz, P. W. (2004) · Placenta · doi:10.1016/j.placenta.2004.03.005 · Cited by 15
Maternal, but not fetal, administration of corticosteroids restricts fetal growth
Newnham, J. P., Evans, S. F., Godfrey, M., Huang, W., Ikegami, M., & Jobe, A. H. (1999) · The Journal of Maternal-Fetal Medicine · doi:10.1002/(sici)1520-6661(199905/06)8:3<81::aid-mfm3>3.3.co;2-e · Cited by 15
Self-citationUse of antenatal corticosteroids for fetal maturation in preterm infants.
Anyaegbunam, W. I., & Adetona, A. B. (1997) · PubMed · Cited by 14
The guinea pig as a model for metabolic programming of adiposity
Castañeda‐Gutiérrez, E., Pouteau, E. B., Pescia, G., Moulin, J., Aprikian, O., & Macé, K. (2011) · American Journal of Clinical Nutrition · doi:10.3945/ajcn.110.000794 · Cited by 14
Effects of betamethasone on plasma levels of estriol, cortisol and hcs in late pregnancy
Maltau, J. M., Stokke, K. T., & Moe, N. (1979) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016347909154040 · Cited by 13
Kinetics of placental lactogen in mid- and late-gestation ovine fetuses
Schoknecht, P. A., Currie, W. B., & Bell, A. W. (1992) · Journal of Endocrinology · doi:10.1677/joe.0.1330095 · Cited by 13
Multiple Courses of Antenatal Corticosteroids for Preterm Birth
Aghajafari, F., Murphy, K. E., Hannah, M., Amankwah, K., Kelly, E., Matthews, S. G., Ohlsson, A., & Saigal, S. (2000) · Journal SOGC · doi:10.1016/s0849-5831(16)31481-1 · Cited by 13
Thakur, A. K., Sase, M., Lee, J. J., Thakur, V., & Buchmiller, T. L. (2000) · Journal of Pediatric Surgery · doi:10.1053/jpsu.2000.6914 · Cited by 12
Burton, G. J., & Jauniaux, E. R. M. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511933806.014 · Cited by 12
Glucocorticoids and placental programming
Vaughan, O. R., Forhead, A. J., & Fowden, A. L. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511933806.015 · Cited by 12
Aida, K., Shi, Q., Wang, J., VandeBerg, J., McDonald, T., Nathanielsz, P., & Wang, X.-L. (2004) · Journal of Steroid Biochemistry and Molecular Biology · doi:10.1016/j.jsbmb.2004.05.004 · Cited by 11
Braun, T., Li, S., Moss, T. J. M., Connor, K. L., Doherty, D. A., Nitsos, I., Newnham, J. P., Challis, J. R. G., & Sloboda, D. M. (2011) · Placenta · doi:10.1016/j.placenta.2011.01.012 · Cited by 10
Self-citationFetal programming of the pancreatic β cells and the implications for postnatal diabetes
Hill, D. J. (1999) · Seminars in Neonatology · doi:10.1016/s1084-2756(99)80012-8 · Cited by 9
Cardiovascular and Pulmonary Effects of Betamethasone during Midtrimester on Fetal Rats
Wu, F. F., Momma, K., & Takao, A. (2009) · Fetal Diagnosis and Therapy · doi:10.1159/000263754 · Cited by 9
Ee, L., HAGAN, R., EVANS, S., & French, N. (1998) · Journal of Paediatrics and Child Health · doi:10.1046/j.1440-1754.1998.00245.x · Cited by 8
Serum Levels of Human Placental Lactogen During and After Prenatal Dexamethasone Therapy
Lange, A. P., & Anthonsen, H. (1980) · Acta Obstetricia Et Gynecologica Scandinavica · doi:10.3109/00016348009154625 · Cited by 8
Stress responses in children after maternal glucocorticoids
Challis, J. R. G. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.183 · Cited by 7
Self-citationEffect of Antenatal Corticosteroids on Fetal Growth and Gestational Age at Birth
Murphy, K. E., Willan, A. R., Hannah, M. E., Ohlsson, A., Kelly, E., Matthews, S. G., Saigal, S., Asztalos, E. V., Ross, S., Delisle, M., et al. (2013) · Obstetric Anesthesia Digest · doi:10.1097/01.aoa.0000429144.49069.83 · Cited by 5
Owens, P. C., Owens, J. A., Lovelock, M., Chan, E., Falconer, J. S., Robinson, J. S., & Smith, R. (1989) · PubMed · Cited by 5
Jansson, T., & Powell, T. L. (2010) · Cambridge University Press eBooks · doi:10.1017/cbo9780511933806.013 · Cited by 3
Antonow‐Schlorke, I., Ebert, M., Li, C., Gschanes, A., Witte, O. W., McDonald, T. J., Nathanielsz, P. W., & Schwab, M. (2006) · Journal of Medical Primatology · doi:10.1111/j.1600-0684.2006.00210.x · Cited by 3
Socias, M., Wiest, W., Schmidt, R. L., Wd, H., & Höhn, N. (1979) · PubMed · Cited by 2
Meaney, M. J., Weaver, I. C. G., Wu, T., Hellstrom, I., Diorio, J. C., & Szyf, M. (2007) · Springer eBooks · doi:10.1007/978-0-387-30405-2_15 · Cited by 2
Challis, J. R. G., Connor, K. L., Matthews, S. G., Lye, S. J., Caniggia, I., Petraglia, F., Imperatore, A., Sloboda, D. M., Li, S., Braun, T., et al. (2009) · KARGER eBooks · doi:10.1159/000221156 · Cited by 1
Self-citation
Research works printed but not linked: 7
- Roberts, 2010, Antenatal Corticosteroids to Reduce Neonatal Morbidity and Mortality. Green Top Guideline No. 7
- Esplin, 2000, Multiple courses of antenatal steroids are associated with delay in long-term psychomotor development in children with birth weight < 1500 grams, Am J Obstet Gynecol, 182, S24
- Cox, 1999, The effect of maternal dexamethasone during early pregnancy on fetal growth, development and the control of glucose homeostasis, J Soc Gynecol Invest, 6, 251
- Burton, 2011, The maternal circulation and placental shape, 161
- Jansson, 2011, 2011 Placental amino acid transporters, 147
- Audette, 2008, Maternal glucocorticoid administartion in early pregnancy and the relationship between 11ßHSD2 mRNA in ovine placenta and fetal weight across gestation, Reprod Sci, 15, 273A
- Braun, 2011, Differential appearance of placentomes and expression of prostaglandin H synthase type 2 in placentome subtypes after betamethasone treatment of sheep late in gestation, Placenta, 32, 295, 10.1016/j.placenta.2011.01.012 · DOI
Cited by
Speiser, P. W., Arlt, W., Auchus, R. J., Baskin, L. S., Conway, G. S., Merke, D. P., Meyer-Bahlburg, H. F. L., Miller, W. L., Murad, M. H., Oberfield, S. E., et al. (2018) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2018-01865 · Cited by 1,234
Glucocorticoids and fetal programming part 1: outcomes
Moisiadis, V. G., & Matthews, S. G. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.73 · Cited by 576
Glucocorticoids and fetal programming part 2: mechanisms
Moisiadis, V. G., & Matthews, S. G. (2014) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2014.74 · Cited by 449
The clinical use of corticosteroids in pregnancy
Kemp, M. W., Newnham, J. P., Challis, J. G., Jobe, A. H., & Stock, S. J. (2015) · Human Reproduction Update · doi:10.1093/humupd/dmv047 · Cited by 216
“Precisely how excess exposure to antenatal corticosteroids might affect pathological changes on the fetus remains unclear; however, several excellent reviews have recently highlighted the potential roles of the fetal HPA axis and the placenta (Braun et al., 2013; Moisiadis and Matthews, 2014).”
BackgroundInfluentialSelf-citationDevelopmental origins of the human hypothalamic-pituitary-adrenal axis
Howland, M. A., Sandman, C. A., & Glynn, L. M. (2017) · Expert Review of Endocrinology & Metabolism · doi:10.1080/17446651.2017.1356222 · Cited by 168
Metadata
- Authors
- Braun, T., Challis, J. R., Newnham, J. P., & Sloboda, D. M.
- Affiliations
- Stiftung Charité (DE)
- The University of Western Australia (AU)
- McMaster University (CA)
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2013-08-22
- Volume
- 34
- Issue
- 6
- Pages
- 885-916
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W1968311559
- Cited by
- 196
- References
- 440
- Citations by year
- 2026: 10 · 2025: 13 · 2024: 16 · 2023: 17 · 2022: 12 · 2021: 29 · 2020: 19 · 2019: 11 · 2018: 17 · 2017: 8 · 2016: 17 · 2015: 13 · 2014: 14
- FWCI
- 2.08
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Endocrine Reviews (publishedVersion)
- PubMed (publishedVersion)
- UWA Profiles and Research Repository (UWA) (submittedVersion)
- Topics
- Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Birth, Development, and Health
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Maternal Mental Health During Pregnancy and Postpartum
- Keywords
- synthetic glucocorticoids, preterm birth, placental function, hypothalamic-pituitary-adrenal axis, developmental programming, fetal growth, fetal brain development, cardiovascular function, reproduction, fetal metabolism
- MeSH terms
- Animals, Disease, Female, Glucocorticoids, Humans, Hypothalamo-Hypophyseal System, Infant, Newborn, Pituitary-Adrenal System, Placenta, Pregnancy, Prenatal Exposure Delayed Effects, Risk Factors, Fetal Development
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.